Boehringer Licenses Marinomed's OTC Nasal Spray Platform For Cold Brand
This article was originally published in The Tan Sheet
Executive Summary
Boehringer Ingelheim continues to build its OTC presence with a deal to market Marinomed's antiviral nasal spray